The Explosive Growth of China's Billion-Dollar Pharmaceutical Market
At present, China's stomach medicine market has shown a very broad potential. According to detailed statistical data, in this vast land, there are more than 120 million patients with stomach diseases, which accounts for 9.23% of the total population of the country, highlighting the universality and severity of stomach problems.
In terms of sales channels, whether it is traditional physical pharmacies or emerging online retail platforms, proprietary Chinese medicine stomach medicine has shown a steady and strong growth trend. Specifically, in the territory of physical pharmacies, in the first half of 2023, the sales of Chinese patent medicine stomach medicine has proudly exceeded the 1.42 billion yuan mark, achieving a steady growth of 1.06% year-on-year. In this prosperous scene, Qingdao Guofeng Pharmaceutical's Kuaiwei tablet and Li Wanshan Pharmaceutical Factory's He Weizheng Pill are emerging, and their sales growth is particularly remarkable, becoming the market leader.
Looking at the online channels, we can also feel that vigorous development vitality. According to data, drug sales in online pharmacies in 2021 have reached 36.8 billion yuan, soaring by 51.5% year-on-year, of which the growth of OTC drugs is like a runaway, unstoppable. In this wave of growth, Yunnan Plant Pharmaceutical's Hawthorn Poria granules and Shaanxi Fangzhou Pharmaceutical's Yangweishu tablets and other stomach medicine brands have stood out with excellent performance, and their sales growth has achieved amazing surpass, both more than 1000%, becoming a shining star in the online market.
China's huge population of stomach disease patients has undoubtedly laid an indestructible cornerstone for the development of the Chinese patent medicine stomach medicine market. Looking forward to the future, with the continuous evolution of residents' lifestyles and the increasing attention of consumers to health issues, the unlimited opportunities contained in the stomach medicine market will be more fully released and displayed. We have reason to believe that in the near future, China's stomach medicine market will usher in a more brilliant chapter of development.
2026-09-04
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
West Asia Tensions Squeeze Pharma Raw Materials
-
Chung Lien Oil’s 8,000-Ton Soybean Oil BaP Scandal: NT$165 Million Fine, 401 Product Recalls, Source Still Unknown
-
India Prepares New Seed and Pesticide Laws
-
When Soybeans Lose Weight, Fertilizers Take the Stage: The Industrial Chain Reaction Behind U.S. Farm Subsidies
-
Fertilizer Prices Put U.S. Farmers Under Pressure
-
ANVISA Updates Additive Rules
-
Cracking Europe: When the Chemical Empire Loses Its Heat
-
The Capital Undercurrent in the Desert: China’s Banks, Saudi Gas, and the “Absent” Chinese Funds
-
US-Iran Conflict Escalates Again as Oil Tops $90 and Petrochemical Feedstock Risks Return
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
Recommend Reading
-
Sun Pharma’s Secret Sauce: Solve the Specific, Win the Market
-
The Oral GLP-1 Cage Match: Orforglipron vs Rybelsus
-
EU Puts Chemicals on Its China De-Risking Watchlist
-
A $25 Billion Bill Hits Global Companies as Chemical Costs Are Repriced
-
IEA Warns Oil Inventories Are Draining Fast as Chemicals Enter Risk Pricing
-
Demand Limited, Polyethylene Narrowly Fluctuating
-
Narrow Increase in Lithium Carbonate Prices During Peak Demand Season for Stockpiling
-
Recent EVA Market Prices Slightly Increased
-
SBR (Styrene Butadiene Rubber) Market Prices Slightly Decline
-
The Market Trend of Butadiene Rubber Weakens